These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 21559250)

  • 1. Short-time intermittent preexposure of living human donors to hyperoxia improves renal function in early posttransplant period: a double-blind randomized clinical trial.
    Montazeri K; Vakily M; Honarmand A; Kashefi P; Safavi M; Taheri S; Rasoulian B
    J Transplant; 2011; 2011():204843. PubMed ID: 21559250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of cyclosporine A pretreatment of deceased organ donors on kidney graft function (Cis-A-rein): study protocol for a randomized controlled trial.
    Orban JC; Fontaine E; Cassuto E; Baumstarck K; Leone M; Constantin JM; Ichai C;
    Trials; 2018 Apr; 19(1):231. PubMed ID: 29665840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recovery of graft function early posttransplant determines long-term graft survival in deceased donor renal transplants.
    Hassanain M; Tchervenkov JI; Cantarovich M; Metrakos P; Paraskevas S; Keith D; Baran D; Fernandez M; Mangel R; Chaudhury P
    Transplant Proc; 2009; 41(1):124-6. PubMed ID: 19249494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early renal transplantation after donor renal angiography affects initial graft function.
    Tutal E; Canver B; Can S; Colak T; Sezer S; Haberal M
    Transplant Proc; 2012 Jun; 44(5):1227-30. PubMed ID: 22663990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic value of time needed on dialysis in patients with delayed graft function.
    Marek C; Thomson B; Shoker A; Luke PP; Moser MA
    Nephrol Dial Transplant; 2014 Jan; 29(1):203-8. PubMed ID: 24166459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective Effects of L-Carnitine Against Delayed Graft Function in Kidney Transplant Recipients: A Pilot, Randomized, Double-Blinded, Placebo-Controlled Clinical Trial.
    Jafari A; Khatami MR; Dashti-Khavidaki S; Lessan-Pezeshki M; Abdollahi A; Moghaddas A
    J Ren Nutr; 2017 Mar; 27(2):113-126. PubMed ID: 28065453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is plasma and urine neutrophil gelatinase-associated lipocalin (NGAL) determination in donors and recipients predictive of renal function after kidney transplantation?
    Buemi A; Musuamba F; Frederic S; Douhet A; De Meyer M; De Pauw L; Darius T; Kanaan N; Wallemacq P; Mourad M
    Clin Biochem; 2014 Oct; 47(15):68-72. PubMed ID: 25011070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and factors associated with delayed graft function in renal transplantation at Carlos Van Buren Hospital, January 2000 to June 2008.
    Sáinz MM; Toro JC; Poblete HB; Perez LF; Nicovani VH; Carrera MG
    Transplant Proc; 2009; 41(6):2655-8. PubMed ID: 19715994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Creatinine reduction ratio and 24-hour creatinine excretion on posttransplant day two: simple and objective tools to define graft function.
    Govani MV; Kwon O; Batiuk TD; Milgrom ML; Filo RS
    J Am Soc Nephrol; 2002 Jun; 13(6):1645-9. PubMed ID: 12039994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk for Delayed Graft Function in Deceased Donor Renal Transplant Patients: A Single-Center Experience From North India.
    Seth A; Sharma A; Kenwar DB; Patil SS; Pandey GS; Kallepalli V; Rally S; Thakur V; Mandwar M; Singh S
    Transplant Proc; 2020; 52(6):1741-1743. PubMed ID: 32434744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for the development of delayed graft function in deceased donor renal transplants.
    Jushinskis J; Trushkov S; Bicans J; Suhorukov V; Shevelev V; Ziedina I; Rozental R
    Transplant Proc; 2009 Mar; 41(2):746-8. PubMed ID: 19328971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of mild hypothermia on serum HMGB1 of brain-dead donors and its impact on kidney transplantation recipients.
    Shan H; Zhang X; Lin ZM; Wang XZ; Mi ZX; Wang YP; Tang ZR; Zhang XD
    Medicine (Baltimore); 2020 May; 99(22):e20425. PubMed ID: 32481442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of donor pretreatment with dopamine on graft function after kidney transplantation: a randomized controlled trial.
    Schnuelle P; Gottmann U; Hoeger S; Boesebeck D; Lauchart W; Weiss C; Fischereder M; Jauch KW; Heemann U; Zeier M; Hugo C; Pisarski P; Krämer BK; Lopau K; Rahmel A; Benck U; Birck R; Yard BA
    JAMA; 2009 Sep; 302(10):1067-75. PubMed ID: 19738091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for delayed graft function in cadaveric kidney transplantation: a prospective study of renal function and graft survival after preservation with University of Wisconsin solution in multi-organ donors. European Multicenter Study Group.
    Koning OH; Ploeg RJ; van Bockel JH; Groenewegen M; van der Woude FJ; Persijn GG; Hermans J
    Transplantation; 1997 Jun; 63(11):1620-8. PubMed ID: 9197357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of low dose dopamine on early graft function in living unrelated kidney donors.
    Hosseinzadeh H; Golzari SE; Abravesh M; Mahmoodpoor A; Aghamohammadi D; Zomorrodi A; Hosseinzadeh P
    Urol J; 2012; 9(1):389-96. PubMed ID: 22395837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perioperative prostaglandin e1 infusion in living donor liver transplantation: A double-blind, placebo-controlled randomized trial.
    Bharathan VK; Chandran B; Gopalakrishnan U; Varghese CT; Menon RN; Balakrishnan D; Sudheer OV; Dhar P; Surendran S
    Liver Transpl; 2016 Aug; 22(8):1067-74. PubMed ID: 27152759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of trimetazidine on renal function in patients with shock].
    Zhang R; Wei J; Yin H; Zhu Y
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 Apr; 26(4):219-22. PubMed ID: 24709491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delayed graft function: predictive factors and impact on outcome in living-related kidney transplantations.
    Senel FM; Karakayali H; Moray G; Haberal M
    Ren Fail; 1998 Jul; 20(4):589-95. PubMed ID: 9713877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunosuppression for delayed or slow graft function in primary cadaveric renal transplantation: use of low dose tacrolimus therapy with post-operative administration of anti-CD25 monoclonal antibody.
    Gonwa TA; Mai ML; Smith LB; Levy MF; Goldstein RM; Klintmalm GB
    Clin Transplant; 2002 Apr; 16(2):144-9. PubMed ID: 11966785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delayed graft function (DGF) after living donor kidney transplantation: a study of possible explanatory factors.
    Salamzadeh J; Sahraee Z; Nafar M; Parvin M
    Ann Transplant; 2012; 17(3):69-76. PubMed ID: 23018258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.